An exclusive mandate was given to Piper Jaffray, a well reputated international investment bank and asset management firm, to support the company in the partnering and/or the externalization of C-Cure®.  

About Celyad

Developing breakthrough pioneering therapies for life-threatening diseases.

Celyad is a biopharmaceutical company, specialized in cell therapy, that is developing landmark technologies aimed at treating severe diseases with poor prognosis. Our scientific approach is inspired by the natural mechanisms that are used by the body to fight disease.

Read more about Celyad

Christian Homsy talked about Celyad on Antipode radio!

Next News

Christian Homsy talked about Celyad on Antipode radio!